Unfortunately, the current gastrointestinal tumor biomarkers, such as carcinoembryonic antigen (CEA) and cancer antigen (CA) 72-4, are not very precise (Matsuoka and Yashiro, 2018). This evidence concerns the gene CEACAM5 and digestive system neoplasm.